| Literature DB >> 32162050 |
Maximilian Riedel1, Bettina Kuschel2.
Abstract
In clinical routine, treatment of pregnant women is a recurring challenge. The frequent opacity of current studies, lack of reliable sources of information and the general insecurity of pregnant women towards systemic drug treatment leads to difficult clinical decision making. Potent therapies with sufficient clinical experience in terms of safety of application are available for most diseases seen in pregnancy. After careful evaluation of potential benefits and risks of a therapy, not only the optimal choice of a medical treatment, but also adequate control of clinical symptoms and interdisciplinary care are crucial for a safe pregnancy.Entities:
Keywords: Benefit-risk assessment; Contraindication; Medication; Pregnancy; Safety
Mesh:
Substances:
Year: 2020 PMID: 32162050 DOI: 10.1007/s00105-020-04560-z
Source DB: PubMed Journal: Hautarzt ISSN: 0017-8470 Impact factor: 0.751